|
|
 |
|
Viewing report
|
|
|
|
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
Business Insights, Oct 2010, Pages: 107
India offers significant cost advantages over mature manufacturing hubs in Europe and North America. Both domestic pharmas and contract manufacturers (CMOs) are moving up the value chain into process development and drug discovery services. Many have evolved into Contract Research and Manufacturing Services (CRAMS) players.
The Top 10 Indian CMOs faced a challenging business environment in the fiscal year, 2010 – most saw revenues contract on the previous year. This report analyzes each of the Top 10 CMOs in turn, reviewing growth strategies and recent deals.
Key Features
- Overview of the global contract manufacturing market
- Market dynamics of Indian CMO market
- Profile of the leading 10 players in Indian CMO/CRAMS market
- Key contract manufacturing partnerships in the Indian CMO sector
- Key trends and opportunities in Indian CMO market
- Major success factors in Indian CRAMS market
- Strategic growth analysis including SWOT profiles of leading 10 players in Indian CMO market
- Short profile of other leading players
Key Benefits
- Analyze the competitive positioning and outlook for each of the Top 10 Indian CMOs/CRAMS companies.
- Develop insights on the Indian CMO market, including market size forecast, and future outlook of global CRAMS industry and opportunities in India.
- Discover contract manufacturing deals that are shaping the development of the market.
- Learn the key factors for success in the CMO market.
- Understand the major issues affecting the Indian CMO industry.
- Assess the financial performance and growth strategies of leading companies in Indian CMO market.
Key findings
The global pharmaceutical contract manufacturing market can be categorized into injectables, solid and liquid dosage forms. Solid dosage is the largest segment by revenue, but the injectable segment is expected to show greatest growth.
Asian CMOs started with large-scale manufacturing for generic and research driven companies are now acquiring assets in the US and Europe to enter the discovery and development segment of the pharmaceutical value chain.
India, riding on its cost-value proposition comprising low-cost skilled manpower and technical capabilities is strongly positioned to capture a significant portion of the growing CMO market. The CRAMS market will continue to provide high growth opportunity and companies which offer reliable services with a significant value proposition in terms of costs and technology will succeed.
India has already emerged as one of the leading cost-competitive and quality manufacturing hubs for many global players including big pharma companies. Moreover, the current economic crisis along with the continuous pricing pressure and pro-generic agenda are driving pharma companies to leverage the strengths of Indian pharma manufacturers.
Drivers of the Indian CMO market include the high number of FDA approved manufacturing facilities, large and growing talent pool and continuing cost advantages. Resistors include intellectual property concerns, competition from China, and safety concerns.
Key questions answered by this report
- What are the key trends of Indian contract manufacturing industry?
- Which companies will drive the future of the Indian CMO market?
- What are the strengths, weaknesses, threats, and opportunities of the leading CMOs in India?
- How was the financial performance of leading players in the Indian CMO market affected by the recent economic downturn?
- Which companies are best positioned to succeed in Indian CMO market in the next five years?
- How are the growth strategies of leading Indian CMOs such as Jubilant Organosys, Dr. Reddy’s, Divis Laboratories, Dishman, Piramal Healthcare, Hikal, Shasun, and Biocon evolving?
- Which are the key contract manufacturing partnerships that will shape the future of Indian CMO market?
Customers who bought this item also bought
Emerging Trends in Active Pharmaceutical Ingredient Outsourcing
Industry Insight - CRAMS (Contract Research And Manufacturing Services) in India
Key Players in Pharmaceutical Contract Manufacturing: Market Developments, Outsourcing Hotspots and Growth Strategies
The CMO Market Outlook to 2017
Indian CRAMS Industry
India's TOP 200 Pharma Company Profiles
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Global Biopharma Outlook 2011: India Pharma
Indian Pharmaceutical Industry, Q4 2011
The Future of Contract Manufacturing - Market Forecasts to 2015 and Key Trends
|
|
|
|
